Treatment of VT of Purkinje fiber origin: ablation targets and outcome
|
|
|
- Tracy Harris
- 5 years ago
- Views:
Transcription
1 Treatment of VT of Purkinje fiber origin: ablation targets and outcome Ch. Piorkowski University Leipzig - Heart Center - Dept. of Electrophysiology Leipzig, Germany
2 Presenter Disclosure Information Gerhard Hindricks has received honoraria for lectures from Biosense, Stereotaxis, St. Jude Medical, Biotronik Gerhard Hindricks is a member of the Advisory Board / consultant for Biosense, St. Jude Medical, Biotronik, Stereotaxis, Cyberheart
3 Catheter ablation of Purkinje-triggered VT The successful mapping and ablation of polymorphic ventricular tachycardia and ventricular fibrillation was introduced by Haissaguerre and colleagues (LQT / Brugada patients). Their observations and scientific work opened up a new window for interventional electrophysiology, i.e. Catheter ablation of VF. The patient population studied so far is small, however, over the years several groups have contributed their experience and to extend the potential option for catheter ablation to other patient subsets.
4 Catheter ablation of Purkinje-triggered VT Catheter ablation has of Purkinje triggered VT / VF has been successfully reported: - idiopathic VT / VF - Brugada Syndrome - LQTs - post MI - after AVR - myocarditis - dilated cardiomyopathy
5 Catheter ablation of Purkinje-triggered VT Catheter ablation has of Purkinje triggered VT / VF has been successfully reported: - idiopathic VT / VF - Brugada Syndrome - LQTs - post MI - after AVR - myocarditis - dilated cardiomyopathy
6 Catheter ablation of Purkinje-triggered VT 66-year old male CAD, LVEF 45%, underwent CABG 7 days after CABG recurrent pleomorphic and polymorphic VT and VF coronary angiography, RCA-stent VT/VF remained, > 200 defibrillations
7 Recurrent VT/VF 10 days after CABG
8 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
9 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
10 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
11 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
12 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
13 Transseptal LV-mapping
14 LV-mapping: Morphology I I II V1 V5 ABL
15 LV-mapping: Morphology II I II V1 V5 ABL
16 LV-mapping: Substrate morphology I and II I II V1 V5 ABL
17 Case I: After successful ablation of VT/VF
18 Ablation of ventricular tachycardia: Electrical storm/polymorphic VT early after AMI Circulation 2003 JACC 2003
19 Catheter ablation of Purkinje-triggered VT 16-year old girl 09/05 palpitations and pre-syncope documentation of wide-qrs tachycardia (290 ms) slightly reduced LVEF (55%), RV normal
20 Catheter ablation of Purkinje-triggered VT normal coronary arteries, LV-biopsy myocarditis (herpes virus, HHV6) recurrent ventricular tachycardia ICD-implantation Re-admission with incessant VT
21 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
22 Holter-ECG CL 290 ms
23 12-lead-ECG I II III avr avl avf V1 V2 V3 V4 V5 V6
24 Endocardial mapping
25 Ventricular tachycardia exit site I II V1 V6 HBE RVA
26 Pace mapping at exit site I II III avr avl avf V1 V2 V3 V4 V5 V6
27 Endocardial mapping
28 Endocardial mapping - substrate I II V1 V6 HBE RVA
29 Bode et al., PACE 2010
30 Catheter ablation of VT / VF: Leipzig data 14 patients with focal triggered VT/VF 8/14 post MI 2/14 post AVR 3/14 slightly impaired LV-function one myocarditis Ablation targets were septal LV in 12/14, LV and RV in 3/14, septal and free wall in 2/14. Acute termination was achieved in all pts., recurrence of any VT/VF after 26±14 months was 3/14.
31 Knecht et al.; JACC 2009
32 Catheter ablation of idiopathic VF 30/38 pts. (81%) had spontaneous VPB 8/38 pts. (19%) had no spont. Acivity VF triggered from the right PS 16 pts., the left PS in 14 pts., and both in 3 pts. a mean of 1.7±2.0 VBS were targeted Knecht et al.; JACC 2009
33 Catheter ablation of idiopathic VF during FU (6 yrs) 7/38 pts. developed recurrence of VF within a median of 24 months (1-60 mo). 5/7 pts. underwent re-ablation, 4/5 pts. had new VPB morphology, only one had a recurrence of clinical VPB all pts. underwent successful re-ablation without recurrence in the next 28 months. Knecht et al.; JACC 2009
34 Summary Focal triggered VT/VF can be observed in the absence of organic heart disease as well as in patients with a variety of cardiovascular diseases. Localization of such triggers is possible, the Purkinje system seems to play a predominant role. However, PVB activity is a necessary for mapping and successful ablation. Recurrence of VF/VF is infrequent, however, as a rule, ICD implantation is recommended to prevent SCD as a result of arrhythmia recurrence.
Outflow Tract Ventricular Tachycardia Always Benign?
Outflow Tract Ventricular Tachycardia Always Benign? Arash Arya, M.D. Department of Interventional Electrophysiology Heart Center University of Leipzig Disclosures: NONE Outflow Ventricular Tachycardia
Inappropriate electrical shocks: Tackling the beast
ESC Paris 2011 Inappropriate electrical shocks: Tackling the beast Gerhard Hindricks University of Leipzig Heart Center Dept. of Electrophysiology ESC Paris 2011 Inappropriate electrical shocks: Tackling
Idiopathic Ventricular Tachycardia Need for an Update in EHRA/HRS Consensus?
Idiopathic Ventricular Tachycardia Need for an Update in EHRA/HRS Consensus? Arash Arya, M.D. Department of Interventional Electrophysiology Heart Center University of Leipzig Disclosures: NONE Idiopathic
Repeat procedures: the best approach
ESC Stockholm 2010 Repeat procedures: the best approach Gerhard Hindricks, MD University Leipzig - Heart Center - Dept. of Electrophysiology Leipzig, Germany Presenter Disclosure Information Gerhard Hindricks
Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center
Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac
Ablative Therapy for Ventricular Tachycardia
Ablative Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS 2 nd Annual UC Davis Heart and Vascular Center Cardiovascular Nurse / Technologist Symposium May 5, 2012 Disclosures Research
Tachycardias II. Štěpán Havránek
Tachycardias II Štěpán Havránek Summary 1) Supraventricular (supraventricular rhythms) Atrial fibrillation and flutter Atrial ectopic tachycardia / extrabeats AV nodal reentrant a AV reentrant tachycardia
Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know
Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden
Erik Wissner, MD, F.A.C.C. Asklepios Klinik St. Georg Hamburg, Germany on behalf of the VTACH Study group
Impact of Inducibility of VT during Ablation and Acute Success of Catheter Ablation on Survival Free from VT/VF and ICD Shocks: Lessons from the VTACH Study Erik Wissner, MD, F.A.C.C. Asklepios Klinik
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:
The patient with electric storm
The complex patient in the cardiac care unit: The patient with electric storm Helmut U. Klein University of Rochester Medical Center Heart Research Follow-up Program and Isar Heart Center Muenchen Presenter
NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010
NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have a financial interest/arrangement or affiliation with
Tachycardia Devices Indications and Basic Trouble Shooting
Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and
ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ
ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ ΣΔΛΙΟ ΠΑΡΑΚΔΤΑÏΓΗ ΓΙΔΤΘΤΝΣΗ ΔΤ Α Καρδιολογική Κλινική ΑΠΘ, Νοζοκομείο ΑΧΕΠΑ, Θεζζαλονίκη NO CONFLICT OF INTEREST INTRODUCTION Sustained VT is an important cause
The patient with (without) an ICD and heart failure: Management of electrical storm
ISHNE Heart Failure Virtual Symposium April 2008 The patient with (without) an ICD and heart failure: Management of electrical storm Westfälische Wilhelms-Universität Münster Günter Breithardt, MD, FESC,
Focus on the role of Catheter Ablation: Simple cases Intermediate level Difficult cases (and patients) Impossible (almost )
22nd SHA Scientific Session 21 24 February 2011, Riyadh, KSA Management of Ventricular Arrhythmias: an Overview Corrado Carbucicchio Ventricular Intensive Care Unit Cardiac Arrhythmias Research Centre
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease
The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology
Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks
Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks Alireza Ghorbani Sharif, MD Interventional Electrophysiologist Tehran Arrhythmia Clinic January 2016 Recurrent ICD shocks are associated
Ventricular Arrhythmias
Presenting your most challenging cases Venice Arrhythmias Ventricular Arrhythmias Gioia Turitto, MD Presenter Disclosure Information A questionable indication for CRT-D in a patient with VT after successful
Advances in Ablation Therapy for Ventricular Tachycardia
Advances in Ablation Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS Director, Cardiac Electrophysiology Training Program University of California, San Francisco For those of you who
Urgent VT Ablation in a Patient with Presumed ARVC
Urgent VT Ablation in a Patient with Presumed ARVC Mr Alex Cambridge, Chief Cardiac Physiologist, St. Barts Hospital, London, UK The patient, a 52 year-old male, attended the ICD clinic without an appointment
that number is extremely high. It s 16 episodes, or in other words, it s 14, one-four, ICD shocks per patient per day.
Doctor Karlsner, Doctor Schumosky, ladies and gentlemen. It s my real pleasure to participate in this session on controversial issues in the management of ventricular tachycardia and I m sure that will
Who does not need a primary preventive ICD?
Who does not need a primary preventive ICD? Hildegard Tanner, Bern Universitätsklinik für Kardiologie Disclosure of potential conflicts of interest Travel grants for educational purposes from: Biosense
Sudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
Indications for catheter ablation in 2010: Ventricular Tachycardia
Indications for catheter ablation in 2010: Ventricular Tachycardia Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology Laboratories Ospedale San Raffaele, IRCCS, Milan, Italy Europace
Prophylactic ablation
Ventricular tachycardia in ischaemic heart disease. Update on electrical therapy 29 august 2010 Prophylactic ablation Pasquale Notarstefano Cardiovacular Department S. Donato Hospital, Arezzo (IT) Prophylactic
Presenter Disclosure Information
Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic
Silvia G Priori MD PhD
The approach to the cardiac arrest survivor Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular Genetics
Arrhythmias (II) Ventricular Arrhythmias. Disclosures
Arrhythmias (II) Ventricular Arrhythmias Amy Leigh Miller, MD, PhD Cardiovascular Electrophysiology, Brigham & Women s Hospital Disclosures None Rhythms and Mortality Implantable loop recorder post-mi
Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias
Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias The Toronto ACS Summit Toronto, March 1, 2014 Andrew C.T. Ha, MD, MSc, FRCPC Cardiac Electrophysiology
J-wave syndromes: update on ventricular fibrillation mechanisms
J-wave syndromes: update on ventricular fibrillation mechanisms Michael Nabauer University of Munich, Germany 28.8.2011 I have no conflicts of interest ECG labelling by Einthoven Circ 1998 Osborn wave
Purkinje-related Arrhythmias
J Arrhythmia Vol 27 No 1 2011 Review Article Purkinje-related Arrhythmias Akihiko Nogami MD Department of Heart Rhythm Management, Yokohama Rosai Hospital, Yokohama, Japan The Purkinje system has been
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong
APHRS Summit 2018 in conjunction with HKCC Heart Rhythm Refresher Course DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong
Improving Patient Outcomes with a Syncope Center. Suneet Mittal, MD
Improving Patient Outcomes with a Syncope Center Suneet Mittal, MD Improving Patient Outcomes with a Syncope Center: Early Risk Stratification of Patients who Require Device Therapy Suneet Mittal, MD Director,
Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC
Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of
ICD Shocks: How to Avoid? Josef Kautzner Department of Cardiology, Institute for Clinical and Experimental Medicine Prague, Czech Republic
ICD Shocks: How to Avoid? Josef Kautzner Department of Cardiology, Institute for Clinical and Experimental Medicine Prague, Czech Republic joka@medicon.cz www.ikem.cz My Disclosures Advisory Board member
State of the Art: Brugada Syndrome Novel diagnostic approaches and risk stratification
State of the Art: Brugada Syndrome Novel diagnostic approaches and risk stratification Lars Eckardt Division Electrophysiology Department of Cardiovascular Medicine University of Münster, Germany I have
Epicardial VT Ablation The Cleveland Clinic Experience
Epicardial VT Ablation The Cleveland Clinic Experience Walid Saliba, MD, FHRS Director, EP Lab Cardiac Electrophysiology Heart and Vascular Institute Epicardial Access in the EP Lab Why Epicardial Special
Novel Approaches to VT Management Glenn M Polin MD
Novel Approaches to VT Management Glenn M Polin MD Medical Director, Electrophysiology Laboratory John Ochsner Heart and Vascular Institute New Orleans, LA Disclosures Pfizer Speaker Bureau Bristol Myers
Ablation of atrial fibrillation Techniques and workflow in AF rotors. G. Hindricks and Ph. Sommer
IDSS - Israel Tel Aviv 2016 Ablation of atrial fibrillation Techniques and workflow in AF rotors G. Hindricks and Ph. Sommer University of Leipzig - Heart Center - Department of Electrophysiology Presenter
Supraventricular arrhythmias in Brugada syndrome. Prof. Dr. Martin Borggrefe Mannheim
Supraventricular arrhythmias in Brugada syndrome Prof. Dr. Martin Borggrefe Mannheim Brugada syndrome 1992-2012 Time interval between description of the disease and discovery of first causal gene Brugada
Clinical Cardiac Electrophysiology
Clinical Cardiac Electrophysiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of
Tailored treatment in Brugada syndrome
Tailored treatment in Brugada syndrome Lars Eckardt Department of Cardiology and Angiology Division of Experimental and Clinical Electrophysiology University of Münster, Germany 45 yr old male preoperative
Ablation of Ventricular Tachycardia in Non-Ischemic Cardiomyopathy
Ablation of Ventricular Tachycardia in Non-Ischemic Cardiomyopathy Fermin C Garcia, MD University of Pennsylvania Cardiac Electrophysiology Philadelphia, PA Nothing to disclose No conflict of interest
Epicardial Approach to Mapping and Ablation of VT: Clinical and ECG Predictors of Epicardial Location
Epicardial Approach to Mapping and Ablation of VT: Clinical and ECG Predictors of Epicardial Location Mathew D. Hutchinson, MD, FACC, FHRS Perelman School of Medicine University of Pennsylvania Presenter
All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager.
All About STEMIs Presented By: Brittney Urvand, RN, BSN, CCCC Essentia Health Fargo Cardiovascular Program Manager Updated 10/2/2018 None Disclosures Objectives Identify signs and symptoms of a heart attack
Use of Catheter Ablation in the Treatment of Ventricular Tachycardia Triggered by Premature Ventricular Contraction
J Arrhythmia Vol 22 No 3 2006 Case Report Use of Catheter Ablation in the Treatment of Ventricular Tachycardia Triggered by Premature Ventricular Contraction sao Kato MD, Toru wa MD, Yasushi Suzuki MD,
- Special VT Cases - Idiopathic Dilated Cardiomyopathy. D. Bänsch
- Special VT Cases - Idiopathic Dilated Cardiomyopathy D. Bänsch Introduction VT Ablation in CAD Strickberger SA, et al. J Am Coll Cardiol 2000 (35: 414-21) Sra J. et al. Pacing Clin Electrophysiol 2001
Ventricular arrhythmias in acute coronary syndromes. Dimitrios Manolatos, MD, PhD, FESC Electrophysiology Lab Evaggelismos General Hospital
Ventricular arrhythmias in acute coronary syndromes Dimitrios Manolatos, MD, PhD, FESC Electrophysiology Lab Evaggelismos General Hospital introduction myocardial ischaemia and infarction leads to severe
Sudden Cardiac Death and Asians Disclosures
Sudden Cardiac Death and Asians Disclosures 7 February 2009 Asian Heart and Vascular Symposium None Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Cardiac Electrophysiology Section University
Ventricular arrhythmias
Ventricular arrhythmias Assoc.Prof. Lucie Riedlbauchová, MD, PhD Department of Cardiology University HospitalMotol and2nd FacultyofMedicine, Charles University in Prague Definition and classification Ventricular
CRT implant using Mediguide: towards fluoroless implant?
CRT implant using Mediguide: towards fluoroless implant? Christopher Piorkowski University Dresden Heart Center - Department of Electrophysiology Presenter Disclosure Information C. Piorkowski has the
Catheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping -
Catheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping - M. Esato, Y. Chun, G. Hindricks Kyoto Ijinkai Takeda Hosptial, Department of Arrhythmia, Japan Kyoto Koseikai
INTRODUCTION. left ventricular non-compaction is a sporadic or familial cardiomyopathy characterized by
A Rare Case of Arrhythmogenic Right Ventricular Cardiomyopathy Co-existing with Isolated Left Ventricular Non-compaction NS Yelgeç, AT Alper, Aİ Tekkeşin, C Türkkan INTRODUCTION Arrhythmogenic right ventricular
2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC
2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline Top Ten Messages Eleftherios M Kallergis, MD, PhD, FESC Cadiology Department - Heraklion University Hospital No actual or potential
3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN
WS # 3 ICD Registry Case Scenarios with Structural Abnormalities Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss specific coding instructions
Catheter Ablation of Recurrent Ventricular Tachycardia Should Be Done Before Antiarrhythmic Therapy with Amiodarone is Tried CONTRA
Catheter Ablation of Recurrent Ventricular Tachycardia Should Be Done Before Antiarrhythmic Therapy with Amiodarone is Tried CONTRA Erik Wissner, MD, F.A.C.C. Director - Magnetic Navigation Laboratory
Results of Catheter Ablation of Ventricular Tachycardia Using Direct Current Shocks
Results of Catheter Ablation of Ventricular Tachycardia Using Direct Current Shocks FRED MORADY, MELVIN M. SCHEINMAN, JERRY C. GRIFFIN, JOHN M. HERRE, and WILLIAM H. KOU From the Divisions of Cardiology,
Recurrent refractory ventricular tachycardia in a patient with LVAD
Monster Cases Recurrent refractory ventricular tachycardia in a patient with LVAD Maurizio Lunati MD Director SC Cardiologia 3 Elettrofisiologia Chairman De Gasperis Cardio Center Department ASST G.O.M.
CLINICAL CARDIAC ELECTROPHYSIOLOGY Maintenance of Certification (MOC) Examination Blueprint
CLINICAL CARDIAC ELECTROPHYSIOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Clinical Cardiac Electrophysiology MOC exam blueprint Based on feedback
Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada
Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada Άννα Κωστοπούλου Επιμελήτρια Α Ωνάσειο Καρδιοχειρουργικό Κέντρο Τμήμα Ηλεκτροφυσιολογίας και Βηματοδότησης BrS: Diagnosis 5:10000 First described
Catheter Ablation of VT Without Structural Heart Disease 성균관의대 온영근
Catheter Ablation of VT Without Structural Heart Disease 성균관의대 온영근 Idiopathic Monomorphic Ventricular Tachycardia Adenosine-sensitive Verapamil-sensitive Propranolol-sensitive Mech (Triggered activity)
Mapping and Ablation of Challenging Outflow Tract VTs: Pulmonary Artery, LVOT, Epicardial
Mapping and Ablation of Challenging Outflow Tract VTs: Pulmonary Artery, LVOT, Epicardial Samuel J. Asirvatham, MD Mayo Clinic Rochester California Heart Rhythm Symposium San Francisco, CA September 8,
4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J.
The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. Wellens MD 1 Einthoven, 1905 The ECG! Everywhere available! Easy and rapid
What Every Physician Should Know:
What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer
Electrical Storm in Coronary Artery Disease. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic July 2016
Electrical Storm in Coronary Artery Disease Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic July 2016 48 yrs. Old diabetic with ACS 48 yrs. Old diabetic with ACS
Do All Patients With An ICD Indication Need A BiV Pacing Device?
Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology
Ventricular Tachycardia Substrate. For the ablationist. Stanley Tung, MD FRCPC Arrhythmia Service/St Paul Hospital University of British Columbia
Ventricular Tachycardia Substrate For the ablationist Stanley Tung, MD FRCPC Arrhythmia Service/St Paul Hospital University of British Columbia Two Attitudes of Ventricular Tachycardia Ablation 1 2C:\Documents
Disclosures 8/29/2016. VT Ablation 2016: Indications and Expected Outcomes. Medtronic: advisory board, review panel. St Jude Medical: speakers bureau
VT Ablation 2016: Indications and Expected Outcomes California Heart Rhythm Symposium 2016 Henry H. Hsia, MD, FACC, FHRS San Francisco VA Medical Center, University of California, San Francisco Disclosures
Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)
Leanna R. Miller, RN, MN, CCRN-CSC, PCCN-CMC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Evaluate common abnormalities that mimic myocardial infarction. Identify
Noninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
Thoranis Chantrarat MD
Device Therapy in Heart Failure Thoranis Chantrarat MD 1 Scope of presentation Natural history of heart failure Primary and secondary prevention ICD and its indication CRT and its indication 2 Severity
Apersistent electrical storm after acute myocardial
Successful Catheter Ablation of Electrical Storm After Myocardial Infarction Dietmar Bänsch, MD*; Feifan Oyang, MD*; Matthias Antz, MD; Thomas Arentz, MD; Reinhold Weber, MD; Jesus E. Val-Mejias, MD; Sabine
ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011
ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off
Implantable Cardioverter Defibrillator (ICD)
Medical Coverage Policy Effective Date... 3/15/2018 Next Review Date... 3/15/2019 Coverage Policy Number... 0181 Implantable Cardioverter Defibrillator (ICD) Table of Contents Related Coverage Resources
Primary Therapy for High Risk LQT Patients Should Be an ICD
Primary Therapy for High Risk LQT Patients Should Be an ICD Raul Weiss MD, FAHA, FACC, FHRS, CCDS Director, Electrophysiology Fellowship Program Associate Professor of Medicine The Ohio State University
NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006
NHS National Institute for Health and Clinical Excellence Issue date: January 2006 Implantable cardioverter defibrillators (ICDs) for arrhythmias Understanding NICE guidance information for people with
Pearls of the ESC/ERS Guidelines 2015 Channelopathies
Pearls of the ESC/ERS Guidelines 2015 Channelopathies Carina Blomstrom Lundqvist Dept Cardiology, Uppsala, Sweden Content 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias
Sudden death as co-morbidity in patients following vascular intervention
Sudden death as co-morbidity in patients following vascular intervention Impact of ICD therapy Seah Nisam Director, Medical Science, Guidant Corporation Advanced Angioplasty Meeting (BCIS) London, 16 Jan,
Case Report Catheter ablation of ventricular tachycardia related to a septo-apical left ventricular aneurysm
Int J Clin Exp Med 2015;8(10):19576-19580 www.ijcem.com /ISSN:1940-5901/IJCEM0014701 Case Report Catheter ablation of ventricular tachycardia related to a septo-apical left ventricular aneurysm Radu Rosu
Imaging and heart failure
Imaging and heart failure Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston, St Jude, BMS imaging, GE Healthcare,
Invasive Risk Stratification: When is it needed?
Inherited Cardiomyopathies and Channelopathies: Who is at risk for Sudden Cardiac Death? Invasive Risk Stratification: When is it needed? Hung-Fat Tse, MD, PhD Department of Medicine The University of
3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives
NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss
Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France
Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France Syncope in advanced heart failure: high risk of sudden death N = 491 patients with HF (NYHA III-IV)
EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs
EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for
Continuous ECG telemonitoring with implantable devices: the expected clinical benefits
Continuous ECG telemonitoring with implantable devices: the expected clinical benefits C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany Carsten.Israel@evkb.de Declaration of
InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions
InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance
Dual-Chamber Implantable Cardioverter-Defibrillator
February 1998 9 Dual-Chamber Implantable Cardioverter-Defibrillator A.SH. REVISHVILI A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Sciences, Moscow, Russia Summary
Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology
SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM
SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM Rio De Janeiro 2016 Sport and Exercise Cardiology Symposium SBC/SOCERJ ACC Sharlene M. Day, MD Associate Professor, Cardiovascular Medicine Director,
PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.
PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. Cardiologist and Electrophysiologist No conflict of interest related to this presentation Objectives 1. PVCs are benign. What is the Evidence?
Prevention of Sudden Death in ARVC
ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück
INNOVATIONS IN DEVICE THERAPY:
INNOVATIONS IN DEVICE THERAPY: Subcutaneous ICDs, Leadless Pacemakers, CRT Indications David J Wilber MD Loyola University Medical Center Disclosures: ACC Foundation: Consultant; Biosense / Webster: Consultant,
Catheter ablation of monomorphic ventricular tachycardia. Department of Cardiology, IKEM, Prague, Czech Republic
Catheter ablation of monomorphic ventricular tachycardia Department of Cardiology, IKEM, Prague, Czech Republic DECLARATION OF CONFLICT OF INTEREST None Ventricular tachycardia ablation in IKEM, Prague
Map-Guided Ablation of Non-ischemic VT. Takashi Nitta Cardiovascular Surgery, Nippon Medical School Tokyo, JAPAN
Map-Guided Ablation of Non-ischemic VT Takashi Nitta Cardiovascular Surgery, Nippon Medical School Tokyo, JAPAN nothing Declaration of Interest Catheter Ablation of Non-ischemic VT Sarcoidosis, 13, 6%
Antony French Consultant Cardiologist & Electrophysiologist
Antony French Consultant Cardiologist & Electrophysiologist Palpitations Unpleasant awareness of rapid or forceful heart beat Not all tachycardias cause palpitations, and not all palpitations are due to
Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF)
Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF) Yiming WU, MD, PhD. Alaska heart and vascular institute. ywu@alaskaheart.com 907-561-3211 19 yo man transferred for out side